-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Editorial ||FREE PAPER||
(1946) Views (232) Full article downloads
Authors: Garry Walsh
Published Date May 2006
Volume 2006:2(1) Pages 1 - 2
DOI: http://dx.doi.org/10.2147/TCRM.S
Garry Walsh
Asthmatic and Allergic Inflammation Group, School of Medicine, University of Aberdeen, UK
Issue one of the second volume of Therapeutics and Clinical Risk Management presents a range of review articles from internationally recognised authors, each of whom addresses an important and apposite topic in the therapeutic management of clinical risk.
Readers of this article also read:
Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis
Clinical and molecular aspects of glucocorticoid resistant asthma
Oblimersen for the treatment of patients with chronic lymphocytic leukemia
Montelukast: its role in the treatment of childhood asthma
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
